Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis

Journal of Oral Pathology and Medicine

Volumn 27, Issue 5, 1998, Pages 197-201

  Ue, Teruyoshi ^a   Yokozaki, Hiroshi ^b   Kagai, Kiyoshi ^a   Higashikawa, Koichiro ^a   Yasui, Wataru ^b   Sugiyama, Masaru ^a   Tahara, Eiichi ^b   Ishikawa, Takenori ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

CD44; Differentiation; Metastasis; Oral squamous cell carcinoma

Indexed keywords

EID: 0032077395     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1998.tb01941.x     Document Type: Article

References (36)

1. STAMENKOVIC I, ARUFFO A, AMIOT M, SEED B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10: 343-8.
2. JACKSON DG, BUCKLEY J, BELL JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extra-cellular domain. J Biol Chem 1992; 267: 4732-9.
3. SCREATON GR, BELL MV, JACKSON DG. CORNELIS FB, GERTH U, BELL JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160-4.
4. SCREATON GR, BELL MV, BELL JI, JACKSON DG. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J Biol Chem 1993; 268: 12235-8
5. GUNTHERT U, HOFMAN M, RUDY W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
6. KOOPMAN G, HEIDER KH, HORST E, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44 J Exp Med 1993; 177: 897-904.
7. HOFMANN M, RUDY W, ZÖLLER M et al. CD44 splice variants confer metastatic behaviour in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51: 5292-7.
8. HEIDER KH, HOFMAN M, HORS E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenocarcinomatous polyps. J Cell Biol 1993; 120: 227-33.
9. DALL P, HEIDER KH, HEKELE A, et al. Surface protein expression and mRNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 1994; 54: 3337-41.
10. HEIDER KH, DÅMMRICH J, SKROCH-ANGEL P, et al. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinoma and normal gastric mucosa. Cancer Res 1993; 53: 4197-203.
11. BROWN TA, BOUCHARD T, ST JOHN T, et al. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 1991; 113: 207-21.
12. KUGELMAN LC, GANGULY S, HAGGERTY JG, WEISSMAN SM, MILSTONE LM. The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44. J Invest Dermatol 1992; 99: 381-5.
13. HUDSON DL, SLEEMAN J, WATT FM. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci 1995; 108: 1959-70.
14. HUDSON DL, SPEIGHT PM, WATT FM. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them Int J Cancer 1996; 66: 457-63.
15. HEROLD-MENDE C, SEITER S, BORN AI. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinoma of the head and neck. J Pathol 1996; 179 66-73.
16. RIKIMARU K, TODA H, TACHIKAWA N, ENOMOTO S, KAMATA N. Growth of the malignant and nonmalignant human squamous cells in a protein-free defined medium. In Vitro Cell Dev Biol 1990; 26: 849-56.
17. HIROKOSHI M, KIMARU Y, NAGURA H, ONO T, ITO H. A new cell line derived from human carcinoma of the gingiva. I. Its establishment and morphological studies. Jpn J Oral Surg 1974; 2: 100-6.
18. MOROYAMA T, MIYAUCHI S, AKEMI T, SUGATA T, TAKADA K. Establishment and characterization of a human tumor cell line (Nakata-1) derived from squamous carcinoma of the buccal mucosa. Proc Jpn Can Assoc 1986; 44: 242-50.
19. MIYAUCHI S, MOROYAMA T, SAKAMOTO T, OKAMOTO T, TAKADA K. Establishment of human tumor cell line (Ueda-1) derived from squamous cell carcinoma of the floor of the mouth. Jpn J Oral Maxillofac Surg 1985; 31: 1347-51.
20. EAGLE H. Propagation in a fluid medium of a human epidermoid carcinoma. Proc Soc Exp Biol Med 1955; 89: 362-4.
21. GEY GO, COFFMAN GW, et al. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 1952; 12: 264-5.
22. HAYASHIDO Y, SHIRASUNA K, MATSUYA T. Effect of epidermal growth factor on invasion of human squamous cell carcinoma cells into collagen gel. The cancer J 1991; 4: 257-62.
23. PRIME SS, NIXON SVR, CRANE IJ, et al. The behaviour of human oral squamous cell carcinoma in cell culture. J Pathol 1990; 160: 259-69
24. OCHIAI A, YASUI W, TAHARA E. Growth-promoting effect of gastrin in human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 1985; 76: 1064-71.
25. HOJO H. Establishment of culture cell lines of human stomach cancer. Niigata Igaku Zasshi 1977; 91: 737-52.
26. General rules for clinical and pathological studies on head and neck cancer, 2nd edn. Tokyo: Kanehara. 1991.
27. MATSUMURA Y, SUGIYAMA M, MATSUMURA S, et al. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 1995; 177: 11-20.
28. YOKOZAKI H, ITO R, NAKAYAMA H, KUNIYASU H, TANIYAMA K, TAHARA E. Expression of CD44 abnormal transcripts in human gastric carcinomas. Cancer Lett 1994; 83: 229-34.
29. HIGASHIKAWA K. YOKOZAKI H, UE T, et al. Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues. Int J Cancer 1996; 66: 11-7.
30. cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 1993; 43: 36-41.
31. ISHII S, FORD R, THOMAS P. CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen. Surg. Oncol 1993; 2: 255-64.
32. ROYE GD, MYERS RB, BROWN D, POCZATEK R, BEENKEN SW, GRIZZLE WE. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus, Int J Cancer 1996; 69: 254-8.
33. GANSAUGE F, GANSAUGE S, ZOBYWALSKI A. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas. Cancer Res 1995; 55: 5499-503.
34. KAYFMANN M, HEIDER KH, SINN HP, MINCKWITZ G, PONTA H, HERRLICH P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615-9.
35. BENNETT KB, JACKSON DG, SIMON JC, et al. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995: 128: 687-98.
36. BARTOLAZZI A, JACKSON D, BENNETT K, et al. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 1995; 108: 1723-33.